Risk Communication Advisory Committee; Notice of Meeting, 9619-9620 [E9-4645]

Download as PDF 9619 Federal Register / Vol. 74, No. 42 / Thursday, March 5, 2009 / Notices from the Mississippi Delta advisory area, and individuals in the Mississippi Delta area who consume wild-caught fish from the advisory area. FDA estimates that the survey will take approximately 18 minutes to complete, for a total burden of 300 hours (1,000 x 0.3 = 300). FDA will conduct 6 cognitive interviews and 20 pretests prior to fielding the survey, for a total additional burden of 16 hours. In the Federal Register of October 24, 2008 (73 FR 63487), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received. FDA estimates the burden of this collection of information as follows: TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN 1 No. of respondents Activity Cognitive Interviews Annual frequency per response Total annual responses Hours per response Total hours 6 1 6 1 6 Pretest 20 1 20 .5 10 Survey 1,000 1 1,000 .30 300 Total 316 1 There are no capital costs or operating and maintenance costs associated with this collection of information. FDA’s burden estimate is based on the agency’s prior experience with surveys similar to the proposed survey. Dated: February 24, 2009. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E9–4644 Filed 3–4–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Risk Communication Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. jlentini on PROD1PC65 with NOTICES ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Risk Communication Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on April 30, 2009, from 8 a.m. to 5 p.m. and May 1, 2009, from 8 a.m. to 2 p.m. Location: Food and Drug Administration, Center for Drug Evaluation and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers Lane, Rockville, MD. Contact Person: Lee L. Zwanziger, Office of the Commissioner, Office of Policy, Planning and Preparedness, VerDate Nov<24>2008 16:49 Mar 04, 2009 Jkt 217001 Office of Planning, Food and Drug Administration, 5600 Fishers Lane, rm 14–90, Rockville, MD 20857, telephone: 301–827–2895, FAX: 301–827–4050, email: RCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 8732112560. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. Agenda: On both days the Committee will discuss the Agency’s draft risk communication strategic plan and will be asked for comment and further advice, for example, on strategic priorities for research on effective risk communication. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ohrms/ dockets/ac/acmenu.htm, click on the year 2009 and scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 submissions may be made to the contact person on or before April 23, 2009. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. on April 30th and 10:30 to 11:30 a.m. on May 1st. Those desiring to make formal oral presentations should notify the contact person on or before April 23, 2009, and should submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by April 24, 2009. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Lee L. Zwanziger at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/oc/advisory/ default.htm for procedures on public conduct during advisory committee meetings. E:\FR\FM\05MRN1.SGM 05MRN1 9620 Federal Register / Vol. 74, No. 42 / Thursday, March 5, 2009 / Notices Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: February 25, 2009. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E9–4645 Filed 3–4–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration Intent To Request Renewal From OMB of One Current Public Collection of Information: Corporate Security Review AGENCY: Transportation Security Administration (TSA), DHS. ACTION: 60-day notice. jlentini on PROD1PC65 with NOTICES SUMMARY: TSA invites public comment on one currently approved information collection requirement abstracted below that we will submit to the Office of Management and Budget (OMB) for renewal in compliance with the Paperwork Reduction Act. DATES: Send your comments by May 4, 2009. ADDRESSES: Comments may be mailed or delivered to Ginger LeMay, PRA Officer, Office of Information Technology, Transportation Security Administration, 601 South 12th Street, Arlington, VA 20598–6011. FOR FURTHER INFORMATION CONTACT: Ginger LeMay, PRA Officer, Office of Information Technology, TSA–11, Transportation Security Administration, 601 South 12th Street, Arlington, VA 20598–6011; telephone (571) 227–3616; e-mail: ginger.lemay@dhs.gov. SUPPLEMENTARY INFORMATION: Comments Invited In accordance with the Paperwork Reduction Act of 1995, (44 U.S.C. 3501 et seq.), an agency may not conduct or sponsor, and a person is not required to respond to a collection of information, unless it displays a valid OMB control number. Therefore, in preparation for OMB review and approval of the following information collection, TSA is soliciting comments to— (1) Evaluate whether the proposed information requirement is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden; (3) Enhance the quality, utility, and clarity of the information to be collected; and VerDate Nov<24>2008 16:49 Mar 04, 2009 Jkt 217001 (4) Minimize the burden of the collection of information on those who are to respond, including using appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Information Collection Requirement Title: Corporate Security Review (CSR). Type of Request: Renewal of one current public collection. OMB Control Number: 1652–0036. Form(s): Corporate Security Review Form. Affected Public: Surface transportation system owners and operators. Abstract: The Aviation and Transportation Security Act of 2001 (ATSA) (Pub. L. 107–71) requires TSA to oversee the security of the nation’s surface transportation system. Specifically, ATSA grants TSA authority to execute its responsibilities for: • Enhancing security in all modes of transportation; • Assessing intelligence and other information in order to identify threats to transportation security; and • Coordinating countermeasures with other Federal agencies to address such threats, including the authority to receive, assess, and distribute intelligence information related to transportation security (49 U.S.C. 114(d), (f)(1)–(5), (h)(1)–(4)). To support these requirements, TSA assesses the current security practices in the surface transportation sector by way of site visits and interviews through its Corporate Security Review (CSR) program, one piece of a much larger domain awareness, prevention, and protection program in support of TSA’s and Department of Homeland Security’s missions. TSA is seeking to renew its OMB approval for this information collection so that TSA can continue to ascertain information security measures and identify gaps. These activities are critical to its mission of ensuring transportation security. The CSR is an ‘‘instructive’’ review that provides TSA with an understanding of surface transportation owner/operators’ security programs, if they have them. In carrying out CSRs, modal experts from TSA conduct site visits of highway and pipeline assets throughout the nation. The TSA team analyzes the owner’s/operator’s security plan, if the owner/operator has one, and determines if the mitigation measures included in the plan are being implemented. In addition to reviewing the security plan document, TSA PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 inspects one or two assets owned by the operator. At the conclusion of these site visits, TSA completes the Corporate Security Review form, which asks questions concerning eleven topics: Threat assessments, vulnerability assessments, security planning, credentialing, secure areas, infrastructure protection, physical security countermeasures, cyber security, training, communications, and exercises. TSA conducts this collection through voluntary face-to-face visits at the company/agency headquarters of surface transportation owners/operators. Typically, TSA sends one to three employees to conduct a 4–8 hour discussion/interview with representatives from the company/ agency owner/operator. TSA plans to collect information from businesses of all sizes. The annual hour burden for this information collection is estimated to be 612 hours. While TSA estimates a total of 590 potential respondents, this estimate is based on TSA conducting 184 visits per year, each visit lasting 1 day (3–8 hour work day). The total annual cost burden to respondents is $30,000. Number of Respondents: 590. Estimated Annual Burden Hours: An estimated 612 hours annually. Issued in Arlington, Virginia, on February 27, 2009. Ginger LeMay, Paperwork Reduction Act Officer, Office of Information Technology. [FR Doc. E9–4652 Filed 3–4–09; 8:45 am] BILLING CODE 4910–62–P DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration Intent To Request Approval From OMB of One New Public Collection of Information: Canine Program Training Form AGENCY: Transportation Security Administration, DHS. ACTION: 60-day notice. SUMMARY: The Transportation Security Administration (TSA) invites public comment on a new Information Collection Request (ICR) abstracted below that we will submit to the Office of Management and Budget (OMB) for approval in compliance with the Paperwork Reduction Act. The ICR describes the nature of the information collection and its expected burden. The collection involves the on-line submission of names, Social Security E:\FR\FM\05MRN1.SGM 05MRN1

Agencies

[Federal Register Volume 74, Number 42 (Thursday, March 5, 2009)]
[Notices]
[Pages 9619-9620]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-4645]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]


Risk Communication Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Risk Communication Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 30, 2009, from 8 
a.m. to 5 p.m. and May 1, 2009, from 8 a.m. to 2 p.m.
    Location: Food and Drug Administration, Center for Drug Evaluation 
and Research Advisory Committee Conference Room, rm. 1066, 5630 Fishers 
Lane, Rockville, MD.
    Contact Person: Lee L. Zwanziger, Office of the Commissioner, 
Office of Policy, Planning and Preparedness, Office of Planning, Food 
and Drug Administration, 5600 Fishers Lane, rm 14-90, Rockville, MD 
20857, telephone: 301-827-2895, FAX: 301-827-4050, e-mail: 
RCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 8732112560. 
Please call the Information Line for up-to-date information on this 
meeting. A notice in the Federal Register about last minute 
modifications that impact a previously announced advisory committee 
meeting cannot always be published quickly enough to provide timely 
notice. Therefore, you should always check the agency's Web site and 
call the appropriate advisory committee hot line/phone line to learn 
about possible modifications before coming to the meeting.
    Agenda: On both days the Committee will discuss the Agency's draft 
risk communication strategic plan and will be asked for comment and 
further advice, for example, on strategic priorities for research on 
effective risk communication.
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after the meeting. Background material is 
available at https://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on 
the year 2009 and scroll down to the appropriate advisory committee 
link.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
April 23, 2009. Oral presentations from the public will be scheduled 
between approximately 1 p.m. and 2 p.m. on April 30th and 10:30 to 
11:30 a.m. on May 1st. Those desiring to make formal oral presentations 
should notify the contact person on or before April 23, 2009, and 
should submit a brief statement of the general nature of the evidence 
or arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing session. The contact person will 
notify interested persons regarding their request to speak by April 24, 
2009.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Lee L. Zwanziger at 
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at https://www.fda.gov/oc/advisory/
default.htm for procedures on public conduct during advisory committee 
meetings.

[[Page 9620]]

    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 25, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9-4645 Filed 3-4-09; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.